Status:
COMPLETED
Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle Surgery
Lead Sponsor:
Virginia Polytechnic Institute and State University
Conditions:
Retinal Detachment
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
PURPOSE: Scleral buckle surgery is a widely used ophthalmic surgery for the correction of rhegmatogenous retinal detachment. Studies suggest that eye pain is a common and underestimated occurrence aft...
Eligibility Criteria
Inclusion
- Patient must have rhegmatogenous retinal detachment and be scheduled to undergo scleral buckle surgery for correction
Exclusion
- Advanced Glaucoma
- History of corticosteroid responsive elevation in IOP
- Allergy to Triamcinolone Acetonide or other corticosteroids
- Pre-existing chronic pain disorders
- Herpes zoster
- Prior corneal allograft
- Allergy to local anesthetic or penicillin
- Patients unable to consent on own behalf
- Patients unable to communicate pain and nausea levels
- Pregnancy
- Incarceration
Key Trial Info
Start Date :
January 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04701593
Start Date
January 3 2020
End Date
October 20 2022
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vistar Eye Centers
Roanoke, Virginia, United States, 24019